Sensidose Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $9.3M

Sensidose General Information

Description

Sensidose AB is a pharmaceutical company that has developed a system for individualized dosing of tablets, a medical treatment using a dosing device pre-programmed for the patient. The system consists of tablets, containing low doses in each individual tablet. Its product comprises MYFID and FLEXILEV. The micro- tablets are retrieved using an automated dispenser. The dispenser has an inbuilt alarm, delivers doses at the programmed time point, and registers all doses delivered as well as disease symptoms with the help of easy-to-use scales.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Devices and Supplies
Corporate Office
  • Vetenskapsvägen 10
  • 191 38 Sollentuna
  • Sweden
+46 010-707 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sensidose Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 25-May-2023 $9.3M 00.000 00.00 Completed Generating Revenue
3. IPO 12-May-2022 00.000 00.000 Completed Generating Revenue
2. Grant 20-Mar-2019 $131K $990K Completed Generating Revenue
1. Later Stage VC 01-Apr-2008 $990K $990K Completed Generating Revenue
To view Sensidose’s complete valuation and funding history, request access »

Sensidose Patents

Sensidose Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-201708624-D0 System for evaluating dosage parameters Inactive 31-May-2017 000000000
EP-3635729-A1 Systems for evaluating dosage parameters Inactive 31-May-2017 000000000
US-20200168310-A1 Systems for evaluating dosage parameters Inactive 31-May-2017 000000000
CA-3065105-A1 Systems for evaluating dosage parameters Pending 31-May-2017 000000000
GB-201520007-D0 Compacted powder Inactive 12-Nov-2015 A61K9/2072
To view Sensidose’s complete patent history, request access »

Sensidose Executive Team (9)

Name Title Board Seat Contact Info
Philip Slätis Chief Operating Officer & Deputy Chief Executive Officer
Per Holm Chief Technology Officer
Sten-Magnus Aquilonius Ph.D Co-Founder
Jack Spira Ph.D Chief Executive Officer & Board Member
You’re viewing 4 of 9 executive team members. Get the full list »

Sensidose Board Members (10)

Name Representing Role Since
Bo-Ragnar Tolf Ph.D Self Board Member 000 0000
Jack Spira Ph.D Self Chief Executive Officer & Board Member 000 0000
Lasse Tenerz Self Board Member 000 0000
William Gunnarsson Self Board Member 000 0000
You’re viewing 4 of 10 board members. Get the full list »

Sensidose Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sensidose FAQs

  • When was Sensidose founded?

    Sensidose was founded in 1998.

  • Who is the founder of Sensidose?

    Christer Nyström Ph.D and Sten-Magnus Aquilonius Ph.D are the founders of Sensidose.

  • Who is the CEO of Sensidose?

    Jack Spira Ph.D is the CEO of Sensidose.

  • Where is Sensidose headquartered?

    Sensidose is headquartered in Sollentuna, Sweden.

  • What is the size of Sensidose?

    Sensidose has 8 total employees.

  • What industry is Sensidose in?

    Sensidose’s primary industry is Other Devices and Supplies.

  • Is Sensidose a private or public company?

    Sensidose is a Private company.

  • What is the current valuation of Sensidose?

    The current valuation of Sensidose is 00.00.

  • What is Sensidose’s current revenue?

    The current revenue for Sensidose is 00000.

  • How much funding has Sensidose raised over time?

    Sensidose has raised $3.47M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »